BLT announced the report on the issuance of A shares to specific targets, and the company issued a total of 3,204 shares810,000 shares, raising 302.9 billion yuan;The issuance** is 94$50 shares.
The final confirmation of the issuance was 14, including a number of public, private, foreign, etc., among which Ge Weidong is the only individual investor. According to the report, Ge Weidong, a well-known private equity person, was allotted 158 shares730,000 shares, allotted 15 billion yuan, ranking 11th among all allotted objects.
According to the report, the 14 issuers were allocated BLT shares for a 6-month restriction period, and the issuance targets and the final allocation are as follows:
BLT is a high-tech enterprise focusing on industrial-grade metal additive manufacturing, with business covering the R&D and production of 3D printing equipment, metal 3D printing customized products and services, metal 3D printing raw material R&D and production, metal 3D printing process design and development and related technical services, involving aerospace, energy and power, medical dentistry, industrial molds, automobile manufacturing and other fields.
Among them, dentistry-related products are BLT-A160 A160D dental industry professional-grade metal 3D printers, material support: titanium alloy, drill chrome alloy. According to the company's 2022 annual report, the annual operating income in 2022 reached 91.9 billion yuan, and the operating income in the medical field was 7$59 million, with a gross margin of 3248%。
Among the company's research projects, the BLT-BP project, which is expected to have a total investment of 20 million yuan, has completed targeted algorithm improvement for the dental industry.
Special thanks] If there are errors or omissions in this article that need to be corrected, please contact our customer service, and we will prepare a small gift for you at that time, thank you!
Disclaimer] The above content is derived from publicly available information, may be inaccurate, and is for informational purposes only. This article does not constitute investment and decision-making advice to anyone, and Goodtooth does not assume any responsibility for the loss caused by the use of this information, and has the final right to interpret this content.
Good dental industry research.